The Association between Beta-Blocker and Renin Angiotensin System Inhibitor Use After HFrEF Hospitalization and Outcomes in Older Patients

By sjmartinez • December 31, 2022

Gilstrap L, Solomon N, Chiswell K, James O'Malley A, Skinner JS, Fonarow GC, Bhatt DL, Yancy CW, DeVore AD. The Association between Beta-Blocker and Renin Angiotensin System Inhibitor Use After HFrEF Hospitalization and Outcomes in Older Patients. J Card Fail. 2022 Dec 11:S1071-9164(22)01217-9. doi: 10.1016/j.cardfail.2022.11.010. Epub ahead of print. PMID: 36516937.

Tags: Beta Blocker, Cardiology/Epi, heart failure, Outcomes, Publications, RASi

Related Posts

Heart Failure Quality of Care Among Asian Patients in the United States

Huang X, Huffman MD, Kandula NR, Petito LC, Agarwal A, Yancy CW, Fonarow GC, Jhund PS, Mefford MT, Reynolds KL, Khan SS, Shah NS. Heart[...]

Public Reporting of Quality and Clinical Outcomes in the Get With The Guidelines-Stroke Registry

Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]